Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma.
Zimmer L, Vaubel J, Mohr P, Hauschild A, Utikal J, Simon J, Garbe C, Herbst R, Enk A, Kämpgen E, Livingstone E, Bluhm L, Rompel R, Griewank KG, Fluck M, Schilling B, Schadendorf D. Zimmer L, et al. Among authors: livingstone e. PLoS One. 2015 Mar 11;10(3):e0118564. doi: 10.1371/journal.pone.0118564. eCollection 2015. PLoS One. 2015. PMID: 25761109 Free PMC article. Clinical Trial.
Neurocutaneous melanosis: a fatal disease in early childhood.
Livingstone E, Claviez A, Spengler D, Barth H, Stark AM, Hugo HH, Hauschild A. Livingstone E, et al. J Clin Oncol. 2009 May 1;27(13):2290-1. doi: 10.1200/JCO.2008.20.4388. Epub 2009 Apr 6. J Clin Oncol. 2009. PMID: 19349541 No abstract available.
Eczematous malignant melanoma: a wolf in sheep's clothing.
Mensing C, Livingstone E, Schwarz T, Hauschild A. Mensing C, et al. Among authors: livingstone e. Onkologie. 2009 Apr;32(4):206-8. doi: 10.1159/000203334. Epub 2009 Mar 19. Onkologie. 2009. PMID: 19372718
Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma.
Hauschild A, Weichenthal M, Rass K, Linse R, Ulrich J, Stadler R, Volkenandt M, Grabbe S, Proske U, Schadendorf D, Brockmeyer N, Vogt T, Rompel R, Kaufmann R, Kaatz M, Näher H, Mohr P, Eigentler T, Livingstone E, Garbe C. Hauschild A, et al. Among authors: livingstone e. J Clin Oncol. 2009 Jul 20;27(21):3496-502. doi: 10.1200/JCO.2008.21.3892. Epub 2009 May 11. J Clin Oncol. 2009. PMID: 19433681 Clinical Trial.
Malignant melanoma and Wiedemann-Beckwith syndrome in childhood.
Livingstone E, Caliebe A, Egberts F, Proksch E, Buiting K, Schubert C, Claviez A, Siebert R, Hauschild A. Livingstone E, et al. Klin Padiatr. 2010 Nov;222(6):388-90. doi: 10.1055/s-0030-1267152. Epub 2010 Nov 5. Klin Padiatr. 2010. PMID: 21058226
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial.
Egberts F, Gutzmer R, Ugurel S, Becker JC, Trefzer U, Degen A, Schenck F, Frey L, Wilhelm T, Hassel JC, Schadendorf D, Livingstone E, Mauch C, Garbe C, Berking C, Rass K, Mohr P, Kaehler KC, Weichenthal M, Hauschild A. Egberts F, et al. Among authors: livingstone e. Ann Oncol. 2011 Jul;22(7):1667-1674. doi: 10.1093/annonc/mdq648. Epub 2011 Jan 10. Ann Oncol. 2011. PMID: 21220519 Free article. Clinical Trial.
195 results